At the time of the survey, 30% of patients were on no immunosuppressive medications for their irAE, 41% were on corticosteroids and 12% were on a biological agent (TNF or IL-6R inhibitor) for arthritis. The gene discussed is TNF; the disease is arthritic joint disease.